The Royal Marsden National Health Service Trust

The Royal Marsden National Health Service Trust is a research organisation in London, United Kingdom that has taken part in 7 EU-funded projects since 2011, receiving €2.3M in EU funding.

EU funding received€2.3M
EU projects7
As coordinator0
Running now3
First EU project2011
Latest project2026
CountryUnited Kingdom
EU registration (PIC)974652412
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are The Royal Marsden National Health Service Trust's own share of each project, not the project's full budget.

  • Horizon 2020€1.1M · 3 projects
  • FP7 (2007 to 2013)€689k · 1 project
  • Horizon Europe€481k · 3 projects

Projects

7 EU-funded projects, newest first. Each links to the official record.

  • AIM-SAFEPartner

    A Multi-Agent Framework for Safe, Specialised, and Adaptive Clinical Reasoning

    Horizon Europe · 2026–2030 · Project on CORDIS ↗

    €277ktheir share
  • TRANSCEND-XRPartner

    Co-creation and implementation of an intervention to improve the understanding of TesticulaR cANcer late effects and unmet Supportive CarENeeDs of AYA survivors using eXtended Reality.

    Horizon Europe · 2025–2030 · Project on CORDIS ↗

    €204ktheir share
  • e-QuoLAssociated partner

    e-health tools to promote Equality in Quality of Life for childhood to young adulthood cancer patients, survivors and their families - a PanEuropean project supported by PanCare and Harmonic consortia

    Horizon Europe · 2024–2027 · Project on CORDIS ↗

  • ProCAncer-IPartner

    An AI Platform integrating imaging data and models, supporting precision care through prostate cancer’s continuum

    Horizon 2020 · 2020–2025 · Project on CORDIS ↗

    €313ktheir share
  • CLINGLIOPartner

    A Clinical Phase IIB trial with 2OHOA in patients with newly-diagnosed malignant glioma.

    Horizon 2020 · 2017–2022 · Project on CORDIS ↗

    €117ktheir share
  • MEDIRADPartner

    Implications of Medical Low Dose Radiation Exposure

    Horizon 2020 · 2017–2022 · Project on CORDIS ↗

    €679ktheir share
  • PREDICTPartner

    Predicting individual response and resistance to VEGFR/mTOR pathway therapeutic intervention using biomarkers discovered through tumour functional genomics

    FP7 (2007 to 2013) · 2011–2014 · Project on CORDIS ↗

    €689ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • RNA
  • adverse drug reactions
  • arteriosclerosis
  • breast cancer
  • diagnostic imaging
  • drug discovery
  • eHealth
  • epidemiology
  • governance
  • mortality
  • neurobiology
  • nuclear medicine
  • nutrition
  • oncology

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime